Who
Guido J. Neels
Director
Company insider
Files Form 4 as: Director, Elutia; Director, TELA Bio; Director, Bioventus; Director, Axogen; Director, Endologix Inc /de/; Director, Entellus Medical; Director, Biopure; Director, LeMaitre Vascular.
In numbers
- Trades disclosed
- 120
- Buys
- 14
- Sells
- 2
- Bought
- $1.1M
- Sold
- $22.7M
- Companies
- 9
- Companies where not an officer
- 8
- First trade
- 21 Jul 2005
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —106,393 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —106,393 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,925 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,675 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,550 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,550 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,335 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,335 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,925 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,675 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,146 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,146 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 30 Jan 2026filed 2 Feb 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Bought | $21K20,000 at $1.04 | filing |
| 30 Jan 2026filed 2 Feb 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Bought | $21K20,000 at $1.04 | filing |
| 29 Jan 2026filed 29 Jan 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Bought | $16K15,000 at $1.06 | filing |
| 29 Jan 2026filed 29 Jan 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Bought | $16K15,000 at $1.06 | filing |
News
No headline names them, or the companies they trade most, lately.